Saving lives with early breast and ovarian cancer screening
Screening all women over 30 for the most common breast and ovarian cancer causing mutations could prevent millions of cancer deaths worldwide, according to a new study...
Screening all women over 30 for the most common breast and ovarian cancer causing mutations could prevent millions of cancer deaths worldwide, according to a new study...
A new drug targeting a cancer's ability to repair its DNA has shown favourable results in its first clinical trial...
Mini versions of mouse reproductive organs have been used to investigate how the most lethal ovarian cancers develop...
A drug already used to treat breast and ovarian cancer can also significantly delay the progression of prostate cancer...
Analysing the tumour genome and cancer microenvironment can predict an ovarian cancer patient's response to a novel immune-PARP combination treatment, according to a new study...
Scientists from the University of Bristol have found a potential connection between the intake of statins and a reduction in ovarian cancer risk...
By 2022 the world's consumer genetic testing market is expected to quadruple to £200 million, according to The Guardian. But while the popularity of DIY genetic testing has undergone huge expansion in recent years, doctors and scientists have called for a crackdown on tests offered by consumer genetics companies such as 23andMe and AncestryDNA...
by Jen Willows
Direct-to-consumer genetic tests should not be used as a basis for medical decision making, according to two separate studies released last week...
Scientists have developed a blood test that may be able to detect ovarian cancer up to two years earlier than other methods...
An influential health group in the USA has concluded that more women could benefit from wider gene screening for hereditary breast or ovarian cancer...
BioNews, published by the Progress Educational Trust (PET), provides news and comment on genetics, assisted conception, embryo/stem cell research and related areas.